Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1317-1339
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1317
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1317
Figure 7 Heying wuzi formulation reduced pathological damage to retinal tissues.
A: The impact of heying wuzi formulation (HYWZF) on weight; B: The impact of HYWZF on blood glucose changes; C: The number of ganglion cells in retinal tissues by tar violet staining (scar bar: 50 μm); D: Hematoxylin and eosin staining was used to observe retinal tissue structure (scar bar: 50 μm); E: Periodic acid-shiff staining was used to detect the number of acellular capillaries in retinal tissues (scar bar: 50 μm). Compared with the con group, bP value < 0.01; compared with the diabetic model group, dP value < 0.01. HYWZF: Heying wuzi formulation; mod: Diabetic model; Con: Control.
- Citation: Wu JJ, Zhang SY, Mu L, Dong ZG, Zhang YJ. Heyingwuzi formulation alleviates diabetic retinopathy by promoting mitophagy via the HIF-1α/BNIP3/NIX axis. World J Diabetes 2024; 15(6): 1317-1339
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1317.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1317